Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (REGN)


Analysis of Liquidity Ratios

Low level of difficulty


Liquidity Ratios (Summary)

Regeneron Pharmaceuticals Inc., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Current ratio 4.47 3.82 2.56 3.59 3.31
Quick ratio 3.50 2.98 2.13 3.10 2.93
Cash ratio 1.95 1.24 0.84 1.29 1.38

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Regeneron Pharmaceuticals Inc.’s current ratio improved from 2016 to 2017 and from 2017 to 2018.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s quick ratio improved from 2016 to 2017 and from 2017 to 2018.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s cash ratio improved from 2016 to 2017 and from 2017 to 2018.

Current Ratio

Regeneron Pharmaceuticals Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in thousands)
Current assets 6,447,600  4,335,030  3,180,188  2,915,095  2,167,461 
Current liabilities 1,442,800  1,135,483  1,241,495  811,162  654,660 
Liquidity Ratio
Current ratio1 4.47 3.82 2.56 3.59 3.31
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.62 2.26 4.02 1.54 1.45
AbbVie Inc. 0.98 1.28 1.65 1.50 1.41
Allergan PLC 1.13 1.16 2.27 1.03 1.37
Amgen Inc. 2.79 5.49 4.11 4.44 4.95
Biogen Inc. 2.32 2.34 2.55 2.60 2.11
Bristol-Myers Squibb Co. 1.61 1.55 1.55 1.30 1.73
Celgene Corp. 2.23 4.99 3.67 4.77 4.60
Eli Lilly & Co. 1.73 1.32 1.37 1.53 1.09
Gilead Sciences Inc. 3.38 2.74 2.22 2.50 3.07
Johnson & Johnson 1.47 1.41 2.47 2.17 2.36
Merck & Co. Inc. 1.17 1.33 1.78 1.55 1.77
Pfizer Inc. 1.57 1.35 1.25 1.49 2.67
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.70 1.82 2.14 1.92 2.19
Current Ratio, Industry
Health Care 1.52 1.64 1.83 1.73 1.98

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Current ratio = Current assets ÷ Current liabilities
= 6,447,600 ÷ 1,442,800 = 4.47

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Regeneron Pharmaceuticals Inc.’s current ratio improved from 2016 to 2017 and from 2017 to 2018.

Quick Ratio

Regeneron Pharmaceuticals Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 1,467,700  812,733  535,203  809,102  648,719 
Marketable securities 1,342,200  596,847  503,481  236,121  251,761 
Accounts receivable, trade, net 1,723,700  1,538,642  1,343,368  1,152,489  739,379 
Accounts receivable from Sanofi 226,400  193,684  92,989  153,152  121,058 
Accounts receivable from Bayer 293,100  242,014  175,263  162,152  156,962 
Total quick assets 5,053,100  3,383,920  2,650,304  2,513,016  1,917,879 
 
Current liabilities 1,442,800  1,135,483  1,241,495  811,162  654,660 
Liquidity Ratio
Quick ratio1 3.50 2.98 2.13 3.10 2.93
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.03 1.67 3.31 1.04 0.76
AbbVie Inc. 0.78 0.89 1.14 1.21 1.06
Allergan PLC 0.83 0.95 2.00 0.42 0.52
Amgen Inc. 2.44 4.98 3.68 3.97 4.22
Biogen Inc. 1.83 1.78 1.94 1.93 1.54
Bristol-Myers Squibb Co. 1.37 1.30 1.27 1.05 1.26
Celgene Corp. 2.00 4.67 3.24 4.05 4.13
Eli Lilly & Co. 1.20 0.91 0.98 1.04 0.77
Gilead Sciences Inc. 3.15 2.52 1.78 2.07 2.56
Johnson & Johnson 1.08 1.04 2.04 1.77 1.76
Merck & Co. Inc. 0.72 0.83 1.24 1.04 1.19
Pfizer Inc. 0.84 0.93 0.84 1.07 2.07
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.27 1.42 1.69 1.48 1.63
Quick Ratio, Industry
Health Care 1.13 1.29 1.44 1.33 1.48

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 5,053,100 ÷ 1,442,800 = 3.50

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s quick ratio improved from 2016 to 2017 and from 2017 to 2018.

Cash Ratio

Regeneron Pharmaceuticals Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 1,467,700  812,733  535,203  809,102  648,719 
Marketable securities 1,342,200  596,847  503,481  236,121  251,761 
Total cash assets 2,809,900  1,409,580  1,038,684  1,045,223  900,480 
 
Current liabilities 1,442,800  1,135,483  1,241,495  811,162  654,660 
Liquidity Ratio
Cash ratio1 1.95 1.24 0.84 1.29 1.38
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.45 1.08 2.82 0.67 0.42
AbbVie Inc. 0.47 0.59 0.66 0.77 0.73
Allergan PLC 0.33 0.65 1.68 0.13 0.05
Amgen Inc. 2.17 4.62 3.40 3.62 3.86
Biogen Inc. 1.07 1.10 1.43 1.33 0.83
Bristol-Myers Squibb Co. 0.83 0.71 0.72 0.53 0.88
Celgene Corp. 1.49 4.03 2.69 3.33 3.57
Eli Lilly & Co. 0.68 0.55 0.55 0.54 0.43
Gilead Sciences Inc. 2.84 2.19 1.29 1.48 1.76
Johnson & Johnson 0.63 0.60 1.59 1.38 1.32
Merck & Co. Inc. 0.40 0.46 0.83 0.70 0.84
Pfizer Inc. 0.59 0.66 0.57 0.79 1.67
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.87 1.03 1.29 1.08 1.21
Cash Ratio, Industry
Health Care 0.73 0.90 1.03 0.94 1.07

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 2018 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 2,809,900 ÷ 1,442,800 = 1.95

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s cash ratio improved from 2016 to 2017 and from 2017 to 2018.